Format

Send to

Choose Destination
Asian J Androl. 2019 May 28. doi: 10.4103/aja.aja_47_19. [Epub ahead of print]

Role of tumor-associated immune cells in prostate cancer: angel or devil?

Author information

1
Department of Urology, The Second Xiangya Hospital, Central South University, Changsha 410011, China.

Abstract

Prostate cancer is the most common malignancy in the reproductive system of older males. Androgen deprivation therapy (ADT) is an important treatment for prostate cancer patients. However, almost all prostate cancer patients unavoidably progress to the castration-resistant stage after ADT treatment. Recent studies have shown that tumor-associated immune cells play major roles in the initiation, progression, and metastasis of prostate cancer. Various phenotypes of tumor-associated immune cells have tumor-promoting or antitumor functions mediated by interacting with tumor cells. Here, we review the current knowledge of tumor-associated immune cells in prostate cancer.

KEYWORDS:

immune tolerance; prostate cancer; tumor associated immune cells; tumor microenvironment

PMID:
31134920
DOI:
10.4103/aja.aja_47_19
Free full text

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd
Loading ...
Support Center